Mapping lymph flow in oropharyngeal cancer with scans
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study uses a special dye or tracer to map how lymph fluid travels from an oropharyngeal (throat) cancer to nearby lymph nodes. It may help doctors understand the most likely spread pattern and plan future treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a new diagnosis of oropharyngeal cancer (throat cancer)
- Your imaging shows cancer in lymph nodes on one side of the neck (not both sides)
- You have not had prior radiation or surgery to the neck area
- You have no spread to distant parts of the body (like the lungs or bones)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special scan (SPECT-CT) can guide radiation treatment to only the safer/needed side of the neck in people with a one-sided oropharyngeal cancer. It aims to keep cancer control while potentially reducing side effects from unnecessary radiation.
This study compares how doctors manage the lymph nodes in your neck when treating early-stage oral cancer that has grown a little deeper. The goal is to find the best way to prevent or treat any hidden spread of cancer.
This study looks at blood samples to find markers that may predict how well treatment works for HPV-positive throat cancer. It aims to help doctors tailor treatment in the future.
This trial tests a new way to guide radiation treatment for a type of throat cancer that is on one side only. The goal is to see if using a special scan (SPECT-CT) to map lymph drainage can help doctors decide how to treat the neck more precisely and reduce side effects.
This study tests an approach called “adaptive radiotherapy,” where the radiation plan may be adjusted based on how your tumor and anatomy look during treatment. It is for adults with biopsy-proven oropharyngeal (throat) squamous cell carcinoma who are planning curative radiation, with or without chemotherapy.
This trial tests if giving less radiation along with chemotherapy is safe and effective for people with HPV-positive throat cancer. It aims to reduce side effects while still controlling the cancer.
Hear when a new Oropharyngeal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.